Less Ads, More Data, More Tools Register for FREE

WHO vaccine safety panel to issue findings on AstraZeneca on Friday - spokesman

Thu, 18th Mar 2021 09:33

GENEVA, March 18 (Reuters) - The World Health Organization's
vaccine safety panel is now due to issue its findings on the
AstraZeneca COVID-19 shot on Friday, a WHO spokesman
said.

The WHO's global advisory committee on vaccine safety
examined the data on Tuesday and reviewed reports of rare blood
coagulation disorders in people who had received the shot, the
agency has said.

Europe's drug watchdog, which is due to report later on
Thursday, is reviewing a small number of reports of bleeding,
blood clots and low platelet counts in people who have received
AstraZeneca's vaccine.
(Reporting by Stephanie Nebehay)

Related Shares

More News
Today 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by abo...

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.